- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Cancer Resistance via Multifunctional Gold Nanoparticles
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 21, Pages 5510
Publisher
MDPI AG
Online
2019-11-05
DOI
10.3390/ijms20215510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of chemotherapy and Au-nanoparticle photothermy in the visible light to tackle doxorubicin resistance in cancer cells
- (2018) Pedro Pedrosa et al. Scientific Reports
- Dinuclear RuII(bipy)2 Derivatives: Structural, Biological, and in Vivo Zebrafish Toxicity Evaluation
- (2017) Oscar A. Lenis-Rojas et al. INORGANIC CHEMISTRY
- Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening
- (2017) Marie Millard et al. International Journal of Nanomedicine
- Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents
- (2017) Alexandra R. Fernandes et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis, characterization, thermal properties and antiproliferative potential of copper(ii) 4′-phenyl-terpyridine compounds
- (2016) Zhen Ma et al. DALTON TRANSACTIONS
- Accumulating nanoparticles by EPR: A route of no return
- (2016) Romeo Ngoune et al. JOURNAL OF CONTROLLED RELEASE
- In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex
- (2016) Marta Martins et al. Molecular BioSystems
- Mechanisms of drug resistance in colon cancer and its therapeutic strategies
- (2016) Tao Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- ROS homeostasis and metabolism: a dangerous liason in cancer cells
- (2016) E Panieri et al. Cell Death & Disease
- Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
- (2015) Pedro Martins et al. MOLECULES
- Analysis of 473 US Head and Neck Cancer Trials (1996-2014)
- (2015) Anand Devaiah et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Cobalt and Zinc Compounds Bearing 1,10-Phenanthroline-5,6-dione or 1,3,5-Triaza-7-phosphaadamantane Derivatives - Synthesis, Characterization, Cytotoxicity, and Cell Selectivity Studies
- (2013) Telma F. S. Silva et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis
- (2013) João Conde et al. Nanotoxicology
- Nanomaterials and Autophagy: New Insights in Cancer Treatment
- (2013) Elisa Panzarini et al. Cancers
- Design of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing
- (2012) João Conde et al. ACS Nano
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- EGF receptor-targeted nanocarriers for enhanced cancer treatment
- (2012) Alyssa M Master et al. Nanomedicine
- Cetuximab (Erbitux)
- (2010) W. Bou-Assaly et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
- (2010) Hiroshi Maeda BIOCONJUGATE CHEMISTRY
- Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer
- (2010) Shirin Khambata-Ford et al. JOURNAL OF CLINICAL ONCOLOGY
- High Epidermal Growth Factor Receptor Expression in Metastatic Colorectal Cancer Lymph Nodes May Be More Prognostic of Poor Survival Than in Primary Tumor
- (2009) Yanhong Deng et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer
- (2009) Edward S. Kim et al. CANCER
- Pemetrexed plus Cetuximab in Patients with Recurrent Non-small Cell Lung Cancer (NSCLC): A Phase I/II Study from the Hoosier Oncology Group
- (2009) Shadia Jalal et al. Journal of Thoracic Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More